Magle Chemoswed has received positive responses from regulatory agencies for market authorization of its range of advanced wound care products. This provides us with a clear pathway to registration of these developed products. As a strategic market for the Company this is an exciting and welcome development. The first line of products are expected to filed within Europe and the United States in the latter parts of 2018.
/wp-content/themes/magle/assets/img/logo.svg 0 0 Gustaf Ström /wp-content/themes/magle/assets/img/logo.svg Gustaf Ström2018-02-17 21:48:102018-02-17 21:48:10Advanced Wound Care products move forward